Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess the Effects of the Celacade™ System on Mortality and Morbidity in Patients With Chronic Heart Failure

NCT00111969 is registered in ClinicalTrials.gov with Vasogen as lead sponsor.

NCT NCT00111969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00111969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess the Effects of the Celacade™ System on Mortality and Morbidity in Patients With Chronic Heart Failure
Lead sponsor
Vasogen
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2003
Completion date
November 30, 2005
Enrollment
2,016
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, congestive